Cargando…

Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults

Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuft, Colin, Matar, Elie, Menczel Schrire, Zoe, Grunstein, Ronald R, Yee, Brendon J, Hoyos, Camilla M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842516/
https://www.ncbi.nlm.nih.gov/pubmed/36660543
http://dx.doi.org/10.2147/CIA.S361519
_version_ 1784870146326659072
author Tuft, Colin
Matar, Elie
Menczel Schrire, Zoe
Grunstein, Ronald R
Yee, Brendon J
Hoyos, Camilla M
author_facet Tuft, Colin
Matar, Elie
Menczel Schrire, Zoe
Grunstein, Ronald R
Yee, Brendon J
Hoyos, Camilla M
author_sort Tuft, Colin
collection PubMed
description Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population.
format Online
Article
Text
id pubmed-9842516
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98425162023-01-18 Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults Tuft, Colin Matar, Elie Menczel Schrire, Zoe Grunstein, Ronald R Yee, Brendon J Hoyos, Camilla M Clin Interv Aging Review Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population. Dove 2023-01-12 /pmc/articles/PMC9842516/ /pubmed/36660543 http://dx.doi.org/10.2147/CIA.S361519 Text en © 2023 Tuft et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Tuft, Colin
Matar, Elie
Menczel Schrire, Zoe
Grunstein, Ronald R
Yee, Brendon J
Hoyos, Camilla M
Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
title Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
title_full Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
title_fullStr Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
title_full_unstemmed Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
title_short Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
title_sort current insights into the risks of using melatonin as a treatment for sleep disorders in older adults
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842516/
https://www.ncbi.nlm.nih.gov/pubmed/36660543
http://dx.doi.org/10.2147/CIA.S361519
work_keys_str_mv AT tuftcolin currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults
AT matarelie currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults
AT menczelschrirezoe currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults
AT grunsteinronaldr currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults
AT yeebrendonj currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults
AT hoyoscamillam currentinsightsintotherisksofusingmelatoninasatreatmentforsleepdisordersinolderadults